Citadel Advisors
JAGX icon

Citadel Advisors’s Jaguar Health JAGX Stock Holding History

Citadel Advisors’s Portfolio JAGX Stock Details JAGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– -$2.69K – 15102
2022
Q4 		– Hold
0
– – – 14299
2022
Q3 		– Hold
0
– – – 12373
2022
Q2 		– Hold
0
– – – 12629
2022
Q1 		– Hold
0
– – – 13210
2021
Q4 		– Hold
0
– – – 13626
2021
Q3 		– Hold
0
– – – 13421
2021
Q2 		– Hold
0
– – – 12669
2021
Q1 		– Hold
0
– – – 11330

Other funds holding JAGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Citadel Advisors's JAGX Position: Q1 2024 in Review

Citadel Advisors sold out of Jaguar Health (JAGX) in Q1 2024, closing a stake of 4 shares — an estimated $29.3K sold.

Citadel Advisors first reported a position in JAGX in Q4 2023 and held it in 1 quarter. The position peaked at $29.3K in Q4 2023. 14 funds tracked by Wall St. Rank hold JAGX as of Q1 2024.

  • Citadel Advisors reported no remaining Jaguar Health position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 4 Jaguar Health shares in Q1 2024, an estimated $29.3K.
  • Citadel Advisors first reported a position in Jaguar Health in Q4 2023 and held it in 1 quarter.
  • Citadel Advisors's Jaguar Health position peaked at $29.3K in Q4 2023.
  • 14 funds tracked by Wall St. Rank held Jaguar Health as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.